A Phase I Study of Single Subcutaneous Dose of SHR-1894 in Healthy Subjects
A Phase I Study of Single Subcutaneous Dose of SHR-1894 in Healthy Subjects
Recruiting · NCT07414602 · Registry updated 2026-03-18Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| A Phase I Study of Single Subcutaneous Dose of SHR-1894 in Healthy Subjects | Skin and Connective Tissue Diseases, dermatitis, skin disorder | Recruiting | Phase 1 | 2026-03-18 | NCT07414602 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Suzhou Suncadia Biopharmaceuticals Co., Ltd. | 74 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| West China Hospital of Sichuan University | Chengdu | China | 117 |